Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

Abstract

We have investigated the use of a high-throughput organ-on-a-chip platform to select therapies. Our results have raised the possibility to use this technology in personalized medicine to support selection of appropriate drugs and to predict response to therapy in a real time fashion.